E. Slavcheva Simeonova

As seen in: Wiley Online Library

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with E. Slavcheva

Contact E. Slavcheva, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT‐1)

Jan 26, 2024 |

By K. A. Papp, S. Beyska-Rizova, M. L. Gantcheva, E. Slavcheva Simeonova

| Wiley Online Library

INTRODUCTION Psoriasis is an autoimmune inflammatory disease manifested by cutaneous plaques resulting from hyperproliferation of keratinocytes, potentially mediated by their resistance to apoptosis.

Open in Who Shared

See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with E. Slavcheva

Contact E. Slavcheva, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

For PR Teams

Overview

Use Cases

Capabilities

Industries

Introducing Curation Engine

Resources

Library

Commmunity

Customers

Company

E. Slavcheva Simeonova

Get in touch with E. Slavcheva

Actions

Is this you?

Articles

Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT‐1)

Actions

Is this you?

Get in touch with E. Slavcheva